Assessment of Antibody-Titer Changes after Second and Third Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination in Japanese Post-Kidney-Transplant Patients

Assessment of Antibody-Titer Changes after Second and Third Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination in Japanese Post-Kidney-Transplant Patients

Post-renal-transplant patients have a relatively low antibody-acquisition rate following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination. In this study, antibody titers were measured 5–6 months and 3 weeks to 3 months after the second and third SARS-CoV-2 mRNA vaccinati...

Full description

Bibliographic Details
Main Authors: Kumiko Fujieda, Akihito Tanaka, Ryosuke Kikuchi, Nami Takai, Shoji Saito, Yoshinari Yasuda, Takashi Fujita, Masashi Kato, Kazuhiro Furuhashi, Shoichi Maruyama
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Vaccines
Subjects:
SARS-CoV-2
vaccination
kidney transplantation
immunocompromised host
Online Access:https://www.mdpi.com/2076-393X/11/1/134

Internet

https://www.mdpi.com/2076-393X/11/1/134

Similar Items